SCHEMBL24710902

SCHEMBL24710902

Cc1cc(C)c(=O)n([C@@H]2CCCNC2)n1

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TLR8 Q9NR97 2/20 0.43
F10 P00742 1/20 0.42
PIM1 P11309 1/20 0.41
PIM3 Q86V86 1/20 0.41
PIM2 Q9P1W9 1/20 0.41
JAK2 O60674 3/20 0.38
JAK1 P23458 3/20 0.38
TYK2 P29597 2/20 0.38
JAK3 P52333 2/20 0.38
ALDH1A1 P00352 2/20 0.36
KDM4E B2RXH2 1/20 0.36
HSD17B10 Q99714 1/20 0.36
HTR3E A5X5Y0 1/20 0.36
HTR3B O95264 1/20 0.36
HTR2B P41595 1/20 0.36
HTR3A P46098 1/20 0.36
TMEM97 Q5BJF2 1/20 0.36
HTR3D Q70Z44 1/20 0.36
HTR3C Q8WXA8 1/20 0.36
MAPK1 P28482 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29145782 1.00 TLR8 (0.43) TLR8F10PIM1PIM3PIM2
SCHEMBL30022464 0.82 F10 (0.42) TLR8F10PIM1PIM3PIM2
SCHEMBL29145755 0.77 MEN1 (0.41) TLR8PIM1PIM3PIM2JAK2
SCHEMBL24710457 0.77 MEN1 (0.41) TLR8PIM1PIM3PIM2JAK2
SCHEMBL15942127 0.72 KDM5A (0.38) F10PIM1PIM3PIM2ALDH1A1
SCHEMBL30979654 0.72 HTR6 (0.41) TLR8PIM1PIM3PIM2JAK2
SCHEMBL29145776 0.70 KDM5A (0.39) JAK2JAK1JAK3ALDH1A1KDM4E
SCHEMBL29145773 0.70 KDM5A (0.39) JAK2JAK1JAK3ALDH1A1KDM4E
SCHEMBL30905834 0.69 PDE7A (0.48) ALDH1A1ABCB1
SCHEMBL24710472 0.69 CAMK2D (0.39) TLR8PIM1PIM3PIM2JAK2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4352048-A1 COMPOUNDS USEFUL IN THE TREATMENT OR PREVENTION OF A PRMT5-MEDIATED DISORDER Argonaut Therapeutics Limited (GB) 2024-04-17 EP disclosed
CN-117480162-A Compounds for the treatment or prophylaxis of PRMT5 mediated diseases 阿古诺治疗有限公司 2024-01-30 CN disclosed
WO-2022258986-A1 COMPOUNDS USEFUL IN THE TREATMENT OR PREVENTION OF A PRMT5-MEDIATED DISORDER Argonaut Therapeutics Limited (GB) 2022-12-15 WO disclosed
WO-2022258986-A1 COMPOUNDS USEFUL IN THE TREATMENT OR PREVENTION OF A PRMT5-MEDIATED DISORDER Argonaut Therapeutics Limited (GB) 2022-12-15 WO disclosed